association

Full identifier: http://purl.org/np/RA2RqUnRCJvJU4BCc_aaDIS59BFJ2GM1MueMUZXBMvbG0#association

Assigned to 1 class:

Minted in Nanopublication

 RA2RqUnRCJ comment approve/disapprove edit as derived nanopublication create new with same template

This is a local identifier that was minted when the nanopublication was created. http://purl.org/np/RA2RqUnRCJ...#association association https://w3id.org/biolink/vocab/has_population_context has_population_context This is a local identifier that was minted when the nanopublication was created. http://purl.org/np/RA2RqUnRCJ...#context context .
This is a local identifier that was minted when the nanopublication was created. http://purl.org/np/RA2RqUnRCJ...#context context http://www.w3.org/2000/01/rdf-schema#label label "adults" .
This is the identifier for this whole nanopublication. http://purl.org/np/RA2RqUnRCJ... This nanopublication links to the assertion template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate was created from the assertion template http://purl.org/np/RAhNHZw6Ur... RAhNHZw6Ur .
This is a local identifier minted within the nanopublication. http://purl.org/np/RA2RqUnRCJ...#sig sig http://purl.org/nanopub/x/hasSignatureTarget has as target This is the identifier for this whole nanopublication. http://purl.org/np/RA2RqUnRCJ... this nanopublication .
This is a local identifier minted within the nanopublication. http://purl.org/np/RA2RqUnRCJ...#sig sig http://purl.org/nanopub/x/hasAlgorithm has the algorithm (this is a literal) "RSA" .

0000-0002-7641-6446, 25 Aug 2021, 14:52:29 UTC

References

Nanopublication Part Subject Predicate Object Published By Published On
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
0000-0002-7641-6446
2021-08-25T14:52:29.045Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Clozapine is not recommended for OCD due to poor evidence of efficacy [170]. In addition, several case reports and clinical studies support the association of clozapine with worsening or onset of obsessive-compulsive symptoms in patients with a psychotic disorder [171-176]. At least 20% of individuals treated with clozapine (and other antiserotonergic antipsychotics) would experience worsening or emergence of obsessive-compulsive symptoms [177], which are dose-related [178] and generally reversible upon discontinuation of clozapine treatment and switch to a different antipsychotic [179]
0000-0002-7641-6446
2021-08-25T14:52:29.045Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
0000-0002-7641-6446
2021-08-25T14:52:29.045Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
0000-0002-7641-6446
2021-08-25T14:52:29.045Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
0000-0002-7641-6446
2021-08-25T14:52:29.045Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
0000-0002-7641-6446
2021-08-25T14:52:29.045Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
0000-0002-7641-6446
2021-08-25T14:52:29.045Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
0000-0002-7641-6446
2021-08-25T14:52:29.045Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
0000-0002-7641-6446
2021-08-25T14:52:29.045Z

Raw

TriG(txt), JSON-LD(txt), N-Quads(txt), XML(txt)